Current/ Expected Orderbook/ Pending Orders?

The company has initiated exports with initial smaller orders: - Two completed consignments amounting to approximately $250,000 USD. - An upcoming consignment expected around $150,000 USD. Export growth is anticipated as more specialized products receive registration in various countries. Partners in Vietnam and Sri Lanka are actively interested in registering patented formulations. These partners are willing to fund the registration process to expand the product reach. Export orders and specialized product traction are expected to increase over time. No specific large outstanding orderboo

Any current/future new fundraising through debt or equity?

The company is hopeful to complete a fundraising round within the current financial year (FY25). There was a QIP (Qualified Institutional Placement) with a commitment of Rs.150 crores; 25% (Rs.35 crores) was received fully. Due to technical issues and challenging market conditions, the remaining 75% of the QIP amount has not yet been collected. The company will pursue collecting the remaining 75% once market conditions improve. No specific new debt fundraising was explicitly mentioned, but borrowings have reduced due to improved cash flows. Focus remains on improving profitability and cash flo

Any current/future capex/capital investment/strategic investment?

The company is planning a brownfield expansion of its technical plant with a CAPEX of Rs. 90 crores, to be spent mostly over 10-12 months starting from around June. Rs. 7 to 10 crores have already been spent as initial expenses on this expansion at the Gajraula plant in UP. The revenue and EBITDA from the new products manufactured through this project are expected to be higher than the current average, positively impacting overall EBITDA margins starting FY26-27. Strategic investment focus continues on R&D capabilities with planned new product releases, including 3-4 patented products th

Future growth expectations in sales/revenue/volumes?

The company aims for a volume growth of around 20% in revenue for FY25-26, though no specific top-line numbers are given. Growth is expected from new product launches, including 3 patented products projected to add approximately Rs.150 crore in revenue in their first year. Focus is on improving profitability and reducing sales returns rather than aggressive top-line targets. Expansion in branded products and bio stimulants is anticipated to contribute to growth. Seasonal factors and market conditions are considered, with emphasis on greater market acceptance of patented products. Export operat

Future growth expectations in earnings/operating earnings/profits/EPS?

The company is focused on improving profitability and cash flows for FY 25-26, with a disciplined approach. Targeted EBITDA margin is expected to improve significantly, potentially in the range of 15% to 18%. There is no specific top-line growth number given, but an optimistic outlook on revenue growth driven by new product launches and reduced sales returns. Launch of 3-4 patented products and bio stimulants expected to contribute approximately Rs.150 crore in additional revenue in the first year. Focus on cost optimization, restructuring to reduce operating expenses, and better inventory man

IN US

Sale is live|00:00:00left today

Best Agrolife LtdQ1 FY25Fertilizers & Agrochemicals

Best Agrolife Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹15.5P/E: 28.8Market Cap: ₹697 CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

Yes

Order

N/A

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→The company aims for a volume growth of around 20% in revenue for FY25-26, though no specific top-line numbers are given.
→Growth is expected from new product launches, including 3 patented products projected to add approximately Rs.150 crore in revenue in their first year.
→Focus is on improving profitability and reducing sales returns rather than aggressive top-line targets.
→Expansion in branded products and bio stimulants is anticipated to contribute to growth.
→Seasonal factors and market conditions are considered, with emphasis on greater market acceptance of patented products.
→Export operations, currently at initial stages (~$250,000 per order), are expected to increase with registrations in various countries.
→Company expects improved cash flow and working capital management to support growth sustainability.

Margin guidance

Category 1

→The company is focused on improving profitability and cash flows for FY 25-26, with a disciplined approach.
→Targeted EBITDA margin is expected to improve significantly, potentially in the range of 15% to 18%.
→There is no specific top-line growth number given, but an optimistic outlook on revenue growth driven by new product launches and reduced sales returns.
→Launch of 3-4 patented products and bio stimulants expected to contribute approximately Rs.150 crore in additional revenue in the first year.
→Focus on cost optimization, restructuring to reduce operating expenses, and better inventory management to drive bottom-line growth.
→Cash flow improvements and reduction in working capital cycles expected to continue, supporting sustainable earnings growth.
→The company sees FY 25-26 as a positive year with aggressive R&D and product strategy driving value for customers and stakeholders.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→The company is hopeful to complete a fundraising round within the current financial year (FY25).
→There was a QIP (Qualified Institutional Placement) with a commitment of Rs.150 crores; 25% (Rs.35 crores) was received fully.
→Due to technical issues and challenging market conditions, the remaining 75% of the QIP amount has not yet been collected.
→The company will pursue collecting the remaining 75% once market conditions improve.
→No specific new debt fundraising was explicitly mentioned, but borrowings have reduced due to improved cash flows.
→Focus remains on improving profitability and cash flow to limit the need for additional borrowings.
→A Rs.90 crore brownfield expansion project is underway, with CAPEX spending planned mostly in FY26, financed through existing resources or financing.

Order book

→The company has initiated exports with initial smaller orders:
→ - Two completed consignments amounting to approximately $250,000 USD.
→ - An upcoming consignment expected around $150,000 USD.
→Export growth is anticipated as more specialized products receive registration in various countries.
→Partners in Vietnam and Sri Lanka are actively interested in registering patented formulations.
→These partners are willing to fund the registration process to expand the product reach.
→Export orders and specialized product traction are expected to increase over time.
→No specific large outstanding orderbook or pending orders mentioned, but steady progress in building international orders is noted.

Capex plans

Yes

→The company is planning a brownfield expansion of its technical plant with a CAPEX of Rs. 90 crores, to be spent mostly over 10-12 months starting from around June.
→Rs. 7 to 10 crores have already been spent as initial expenses on this expansion at the Gajraula plant in UP.
→The revenue and EBITDA from the new products manufactured through this project are expected to be higher than the current average, positively impacting overall EBITDA margins starting FY26-27.
→Strategic investment focus continues on R&D capabilities with planned new product releases, including 3-4 patented products this year plus bio-stimulants.
→The company aims to increase backward integration, producing more technical products for both domestic and global markets aligned with their specialized materials strategy.
→Investments in brand building and marketing will reduce in the current year due to prior groundwork.

How does Best Agrolife Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Best Agrolife Ltd

Rev 3Mar 1

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Best Agrolife Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio